Comparison of drug therapy with percutaneous coronary interventio

Not Applicable

• Conditions: Chronic Ischemic Heart Disease.; Chronic ischemic heart disease, unspecified; I25.9

• Registration Number: IRCT20211129053210N1
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

More than 70% stenosis in at least one coronary artery
EF more than 30%

Exclusion Criteria

Resistant angina class IV
Treatment-resistant heart failure
Cardiogenic shock
Anatomy inappropriate for PCI
Chronic renal failure
Proximal LAD obstruction
triple vessel disease
Diabetes, smoker

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life: In terms of the patient's clinical symptoms and based on the chronic angina checklist. Timepoint: Measurement of quality of life at the beginning of the study and 6 months after the intervention. Method of measurement: Chronic angina checklist.

Secondary Outcome Measures

Name	Time	Method
Go to the emergency room based on the patient's statements. Timepoint: Evaluation of emergency department visit 6 months after the intervention. Method of measurement: Based on the patient's statements.;Number of hospitalizations based on hospitalization documents. Timepoint: Evaluation of the number of hospitalizations 6 months after the intervention. Method of measurement: Based on hospitalization documents.;Function Class: Angina classification based on the New York Heart Association. Timepoint: Evaluation of class function at the beginning of the study and 6 months after the intervention. Method of measurement: Based on the patient's statements and New York Heart Association.;Ejection fraction based on echocardiographic findings. Timepoint: Ejection fraction at the beginning of the study and 6 months after the intervention. Method of measurement: Based on the patient's echocardiographic evidence.